Conference Reports for NATAP
ID Week 2024
October 16-19
Los Angeles, California
Back
 
Tweet
Pharmacokinetics and Safety of GS-1720 Following Multiple Ascending Doses in a Phase 1a Study in People Without HIV-1
IDWeek 2024 Oct 16-19 LA, CA